Navigation Links
Peripheral Artery Disease (PAD) Patent Granted to Dimera
Date:8/11/2009

PORTLAND, Ore., Aug. 11 /PRNewswire/ -- The U.S. Patent and Trade Office (USPTO) plans to announce patent award approval on August 11 to Dimera Incorporated for treatment of symptoms of Peripheral Arterial Disease (PAD), which is alternatively known as Peripheral Vascular Disease (PVD).

"Method and Kit for reducing the symptoms of peripheral vascular disease," (Number 7572780) covers the period August 11, 2009 through July 28, 2024. Dimera President, Prof. R. Kent Hermsmeyer, said, "We are pleased to announce perhaps the most important of the Dimera patents to date. Dimera plans to further optimize our success in demonstrating the virtues of our advanced transdermal strategy that we have extensively documented in primates to greatly extend normal function in the peripheral circulation."

Hermsmeyer explains that, "The loss of normal function of blood vessels explains deterioration of the peripheral circulation, and that decline in function with age now appears to be preventable. If women and men at the peak of cardiovascular health used our discovery to counter the avoidable fall in essential molecular function - which we have identified and mapped - then the expectation of reduced mobility and even disability with advancing age might be dispelled. Rather than addressing only the symptoms of peripheral vascular disease, Dimera has taken the demanding - but arguably more powerful - approach that demands discovery and understanding of the underlying molecular mechanism at the gene level."

The significance of this patent is one of the premiere successful translations of science - cell and molecular biology - to clinically effective medicine.

About Dimera

Founded by world-renown researchers in 1997 as a pure R&D biotech, Dimera (www.dimera.net) has evolved into a drug development firm specializing in cardiovascular and smooth muscle d
'/>"/>

SOURCE Dimera Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors
2. Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral Arterial Disease Not Statistically Significant
3. ev3 Inc. Receives FDA Clearance to Market EverCross and NanoCross Peripheral Angioplasty Balloons
4. Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets
5. Peripheral Vascular Device Market Insights Webinar
6. FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults
7. Vermillions Roundtable Teleconference Highlights Peripheral Artery Disease Diagnostic Program; Features Commentary from Vascular Medicine Expert
8. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
9. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
10. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
11. FDA Clears OmniWave(TM) Endovascular System for Clot Removal in Peripheral Blood Vessels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... and Cardiff, UK (PRWEB) January 13, 2014 ... development leader with more than 20 years in the ... optics and photonics . Hainsey will serve as the ... to have Dr. Hainsey join SPIE as our Technology ...
(Date:1/14/2014)... January 14, 2014 During the 1600’s through ... as “The Doctor’s Plague.” In this time period, doctors did ... led, at times, to the death of vulnerable patients. In ... know that they may be unwittingly transmitting herpes viruses to ...
(Date:1/14/2014)... 14, 2014 BioMedomics, Inc. , a ... diagnostic platforms and novel disease specific POC tests, announced today ... netting a total of $690,000. The investment is from private ... company. This group of private investors has significant successful experience ...
(Date:1/14/2014)... Translational Biosciences, a subsidiary of ... trial approval for the treatment of rheumatoid arthritis ... from the Comité Nacional de Bioética de la ... (RA) is an autoimmune disease in which the ...
Breaking Biology Technology:Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3BioMedomics, Inc. Closes $690K Round of Financing 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 3
(Date:4/23/2014)... 2 million Food Standards Agency (FSA) project to map ... workers. , Norovirus outbreaks can rapidly affect large ... frozen strawberries infected 11,000 people in Germany, but there ... strains cause infection and which foods are the most ... will produce data that will help the FSA to ...
(Date:4/22/2014)... secret to get your child to behave at the dinner ... Cornell study published in Eating Behaviors , found that ... bite with their front teeth such as drumsticks, whole apples, ... when these foods had been cut. "They were twice ... other kids," said Brian Wansink, Professor and Director of the ...
(Date:4/22/2014)... researchers will lead a five-year, $3 million study to ... affecting the transport of dissolved organic matter (DOM) through ... alter the chemical composition and water quality of the ... the National Science Foundation,s MacroSystems Biology program, researchers will ... which begins in Canada and runs through five U.S. ...
Breaking Biology News(10 mins):Biting vs. chewing 2Connecticut River watershed study will assess impacts of extreme rain events 2Connecticut River watershed study will assess impacts of extreme rain events 3
... Our brains, it turns out, are eco-friendly. A study published ... Venkatesh Murthy and Jakob Sorensen reveals that our brains have ... cells generate and propagate nerve impulses, or action potentials, by ... and out of the cells. Re-establishing the ion equilibrium after ...
... MADISON, WI, OCTOBER 12, 2009 Areas of ... and recreational (not grazing) purposes, i.e. "urban grasslands" are ... are over 150,000 km2of urban grasslands in the U.S. ... about nutrient runoff to streams, lakes, and estuaries and ...
... 13 CareFusion Corporation (NYSE: CFN ), a new ... the EnVe(TM) ventilator - a high-performance critical care ventilator for ... ventilator is 70-80 pounds lighter than other intensive care ventilators ... help hospitals increase the quality of patient care and decrease ...
Cached Biology News:Nitrogen mysteries in urban grasslands 2Nitrogen mysteries in urban grasslands 3CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator 2CareFusion Launches EnVe(TM) Ventilator: 10-Pound High-Performance Critical Care Ventilator 3
A component of the Acridinium protein labeling kit....
... Acridinium NHS ester can ... and nucleic acids. The covalently ... produce chemiluminescence in the presence ... ester-labeled proteins can be used ...
... again Guava is making flow cytometry accessible to ... will appreciate the latest addition to Guavas on-demand ... Mini easy to use, surprisingly affordable, very ... and 3-color detection. The Guava EasyCyte Mini has ...
... The MiniOpticon 2-color real-time PCR detection system holds 48 ... array of 48 LEDs independently excites fluorescence (470-500 nm) ... detects emitted light (523-543 nm and 540-700 nm). This ... MJ Mini thermal cycler. System dimensions are 18 x ...
Biology Products: